Literature DB >> 3139327

Electroimmuno- and immunonephelometric assays of apolipoprotein A-I by using a mixture of monoclonal antibodies.

I Pruvot1, C Fievet, C Durieux, N Vu Dac, J C Fruchart.   

Abstract

The use of mixtures of well-defined monoclonal antibodies may represent a step forward in the standardization of immunochemical assays. We developed and optimized working conditions for using such a mixture to determine apolipoprotein A-I in human sera by two independent techniques (electroimmuno- and immunonephelometric-assays). Six monoclonal antibodies, each addressed to distinct epitopes located at the surface of apolipoprotein A-I, were used in combination to permit a reproducible measurement of the protein, without prior delipidation of samples. Parallel standard curves for a high-density lipoprotein subfraction (HDL3, the primary standard) and a reference serum (the secondary standard) were obtained. Within- and between-run coefficients of variation were acceptable for both methods. Apolipoprotein A-I concentrations, as measured in 60 subjects selected to present a large range of apolipoprotein content by electroimmunoassay (y1) and immunonephelometric assay (y2) with monoclonal antibodies, compared well with those measured by the same techniques but with polyclonal antibodies (x): r1 = 0.96, r2 = 0.99; y1 = 1.19x - 0.11 g/L, y2 = 0.98x. Comparison of results obtained by electroimmunoassay and immunonephelometric assay performed with monoclonal antibodies was also good: r = 0.96; y2 = 1.08y1 + 0.13 g/L.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139327

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.

Authors:  Ivan Tancevski; Sasa Frank; Petra Massoner; Ursula Stanzl; Wilfried Schgoer; Andreas Wehinger; Catherine Fievet; Philipp Eller; Josef R Patsch; Andreas Ritsch
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

2.  Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits.

Authors:  Egon Demetz; Ivan Tancevski; Kristina Duwensee; Ursula Stanzl; Eva Huber; Christiane Heim; Florian Handle; Markus Theurl; Andrea Schroll; Anne Tailleux; Hermann Dietrich; Josef R Patsch; Philipp Eller; Andreas Ritsch
Journal:  Atherosclerosis       Date:  2012-03-23       Impact factor: 5.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.